HI
ABBV icon

Harbour Investments’s AbbVie ABBV Stock Holding History

Harbour Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.8M Sell
221,662
-6,363
-3% -$1.37M 0.75% 22
2026
Q1 		$49.6M Buy
228,025
+55,990
+33% +$12.4M 0.77% 23
2025
Q4 		$39.3M Buy
172,035
+146,611
+577% +$33.4M 0.8% 19
2025
Q3 		$5.89M Buy
25,424
+616
+2% +$125K 0.13% 133
2025
Q2 		$4.6M Buy
24,808
+44
+0.2% +$8.18K 0.12% 160
2025
Q1 		$5.19M Buy
24,764
+1,806
+8% +$351K 0.15% 121
2024
Q4 		$4.08M Buy
22,958
+780
+4% +$143K 0.12% 152
2024
Q3 		$4.38M Sell
22,178
-943
-4% -$176K 0.13% 133
2024
Q2 		$3.97M Buy
23,121
+808
+4% +$134K 0.13% 134
2024
Q1 		$4.06M Buy
22,313
+902
+4% +$155K 0.14% 133
2023
Q4 		$3.32M Buy
21,411
+2,842
+15% +$414K 0.14% 137
2023
Q3 		$2.77M Buy
18,569
+3,888
+26% +$571K 0.14% 147
2023
Q2 		$1.98M Buy
14,681
+34
+0.2% +$4.99K 0.1% 206
2023
Q1 		$2.33M Buy
14,647
+192
+1% +$29.4K 0.13% 150
2022
Q4 		$2.34M Sell
14,455
-9,276
-39% -$1.42M 0.14% 135
2022
Q3 		$3.63M Hold
23,731
– – 0.25% 69
2022
Q2 		$3.63M Buy
+23,731
New +$3.63M 0.25% 69
2021
Q4 		$3.04M Sell
22,478
-53,653
-70% -$6.34M 0.18% 113
2021
Q3 		$8.21M Sell
76,131
-3,903
-5% -$446K 0.26% 68
2021
Q2 		$9.02M Buy
80,034
+4,043
+5% +$455K 0.29% 64
2021
Q1 		$8.22M Buy
+75,991
New +$8.13M 0.3% 64

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbour Investments's ABBV Position: Q2 2026 in Review

Harbour Investments reduced its AbbVie (ABBV) stake by 2.8% in Q2 2026, selling an estimated $1.37M and leaving 221,662 shares worth $55.8M. The position accounts for 0.75% of the portfolio, ranked #22.

Harbour Investments first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harbour Investments held 221,662 shares of AbbVie worth $55.8M as of Q2 2026.
  • Harbour Investments sold 6,363 AbbVie shares in Q2 2026, an estimated $1.37M.
  • AbbVie made up 0.75% of Harbour Investments's portfolio in Q2 2026, its #22 holding.
  • Harbour Investments first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.